Evidence map›Paper›PMID 35948448›Full record

ArticleNeurology2022

Association of AK4 Protein From Stem Cell-Derived Neurons With Cognitive Reserve: An Autopsy Study.

Lei Yu, Yi-Chen Hsieh, Richard V Pearse, Yanling Wang, Vladislav A Petyuk, Julie A Schneider, Aron S Buchman, Nicholas T Seyfried, Philip L De Jager, Tracy L Young-Pearse and 1 more

Open access · greenAbstract read
In one paragraph

Article in Neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Neuroinflammation in Alzheimer disease.Nature reviews. Immunology · 2025
    Review
  7. Article
  8. Article
  9. Person-specific differences in ubiquitin-proteasome mediated proteostasis in human neurons.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  10. Article
  11. Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Lei YuFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York. lei_yu@rush.edu.ORCID 0000-0002-7176-1152
Yi-Chen HsiehFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.
Richard V PearseFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.
Yanling WangFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.
Vladislav A PetyukFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.ORCID 0000-0003-4076-151X
Julie A SchneiderFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.
Aron S BuchmanFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.ORCID 0000-0002-6426-2742
Nicholas T SeyfriedFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.ORCID 0000-0002-4507-624X
Philip L De JagerFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.ORCID 0000-0002-8057-2505
Tracy L Young-PearseFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.
David A BennettFrom the Rush Alzheimer's Disease Center (L.Y., Y.W., J.A.S., A.S.B., D.A.B.) and Department of Neurological Sciences (L.Y., Y.W., J.A.S., A.S.B., D.A.B.), Rush University Medical Center, Chicago, IL; Ann Romney Center for Neurologic Diseases (Y.H., R.V.P., T.L.P.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School (Y.H., R.V.P., T.L.P.), Boston, MA; Pacific Northwest National Laboratory (V.A.P.), Richland, WA; Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Biochemistry (N.T.S.), Emory University, Atlanta, GA; and Center for Translational and Computational Neuroimmunology (P.L.D.), Department of Neurology & Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York.ORCID 0000-0003-3689-554X
Brigham and Women's Hospital · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targetsU01AG061356 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2018 to 2022
$13.7M
Characterizing TDP-43 related hippocampal degeneration and memory loss in agingR01AG067482 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI SCHNEIDER, JULIE A. · 2020 to 2024
$6.8M
Risk Factors, Pathology, and Clinical Expressions of ADRF1AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2014 to 2014
$6.0M
Probing Heterogeneity of Alzheimer's Disease Using iPSCsR01AG055909 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Tracy L YOUNG-PEARSE · 2018 to 2026
$5.7M
Cell and Molecular Consequences of Alzheimer's Disease Genetic Variants on BBB Integrity and FunctionRF1NS117446 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI YOUNG-PEARSE, TRACY L · 2020 to 2020
$3.6M
NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG055909NIA NIH HHS R01 AG067482NIA NIH HHS RF1 AG015819NIA NIH HHS U01 AG061356NINDS NIH HHS RF1 NS117446
6 · The paper itself

Abstract

BACKGROUND AND

objectivesIdentifying protein targets that provide cognitive reserve is a strategy to prevent and treat Alzheimer disease and Alzheimer disease related dementias (AD/ADRD). Previous studies using bulk human brain tissue reported 12 proteins associated with cognitive reserve. This study examined whether the same proteins from induced neurons (iNs) are associated with cognitive reserve of their human donors.

methodsInduced pluripotent stem cell (iPSC) lines were generated from cryopreserved peripheral blood mononuclear cells of older adults who were autopsied as part of the Religious Orders Study or Rush Memory and Aging Project. Neurons were induced from iPSCs using a standard neurogenin2 protocol. Tandem mass tag proteomics analyses were conducted on iNs day 21. Cognitive reserve of their human donors was measured as person-specific slopes of cognitive change not accounted for by common neuropathologies.

resultsThe 53 human donors died at a mean age of 91 years, all were non-Latino White, and 36 (67.9%) were female. Eighteen were diagnosed with Alzheimer dementia proximate to death, and 34 had pathologic AD diagnosis at autopsy. Approximately 60% of the donors had above-average cognitive reserve such that their cognition declined slower than an average person with comparable burdens of neuropathologies. Eight of the 12 candidate proteins were quantified in iNs proteomics analyses. Higher adenylate kinase 4 (AK4) expression in iNs was associated with lower cognitive reserve, consistent with the previous report for brain AK4 expression. DISCUSSION: By replicating cortical protein associations with cognitive reserve in human iNs, these data provide a valuable molecular readout for studying complex clinical phenotypes such as cognitive reserve in a dish.

Indexed as

Alzheimer DiseaseCognitive ReserveAgedAged, 80 and overAutopsyBrainFemaleHumansLeukocytes, MononuclearMaleNeuronsStem Cells

Identifiers

PMID35948448
PMCPMC9694839
OpenAlexW4291020752

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.